Tag: covid-19
Some investors turn to cutting fully remote checks while sheltering in place
By March 16, founder Janine Yancey was tired of playing the waiting game. After watching the stock market take yet another unprecedented nosedive due to coronavirus, she called up a potential investor. “If this isn’t going to happen, let’s call it now,” Yancey said, referring to the close of her…
Read More
Vice lays off 155, as COVID-19 continues to slam media revenue
In a memo titled “The Course Ahead,” Vice Media Group CEO Nancy Dubuc announced a large round of layoffs to staff. The number includes 155 workers — 55 of whom will lose their jobs today. The remaining 100, meanwhile, will be let go in the coming weeks. The figure comprises…
Read More
Big VCs stacked billions in Q1 while smaller firms saw their haul shrink
Q2 2020 is the least-certain quarter I’ve ever covered Alex Wilhelm 7 hours Hello and welcome back to our regular morning look at private companies, public markets and the gray space in between. After spending perhaps more time than we should have recently trying to figure out what’s going on…
Read More
Foxconn’s profits plunged nearly 90%, due to COVID-19 shutdown
As earnings season winds down, we’re getting a solid picture on just how profoundly the COVID-19 pandemic has impacted corporations’ bottomline. Taiwan-based manufacturing giant Foxconn is among those companies that were utterly walloped over the previous quarter. Plant shutdowns — particularly in China — lead to a 90% year-over-year drop…
Read More
Every musician is basically a YouTuber now
Huddled inside a cluttered garage in Los Angeles, Grouplove tries to be itself. Keyboardist Hannah Hooper grins wide as she sings toward the smartphone, attempting to maintain some of the buoyant alt-rock band’s typical electricity, even as she’s squ… Source
Read More
Sorrento finds a coronavirus antibody that blocks viral infection 100% in preclinical lab experiments
Therapeutics company Sorrento has made what it believes could be a breakthrough in potential treatment of SARS-CoV-2, the virus that leads to COVID-19. The company released details of its preclinical research on Friday, announcing that it has found an antibody that provides “100% inhibition of SARS-CoV-2 virus infection of healthy…
Read More